Spain · Delayed Price · Currency is EUR BME:YVIV Statistics
Total Valuation
BME:YVIV has a market cap or net worth of EUR 973.61 million. The enterprise value is 1.70 billion.
| Market Cap | 973.61M |
| Enterprise Value | 1.70B |
Important Dates
The next estimated earnings date is Wednesday, April 14, 2027.
| Earnings Date | Apr 14, 2027 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
BME:YVIV has 732.03 million shares outstanding. The number of shares has increased by 0.76% in one year.
| Current Share Class | 732.03M |
| Shares Outstanding | 732.03M |
| Shares Change (YoY) | +0.76% |
| Shares Change (QoQ) | -1.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 48.84% |
| Float | 374.53M |
Valuation Ratios
The trailing PE ratio is 8.62.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 8.62 |
| Forward PE | n/a |
| PS Ratio | 11.28 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | 34.95 |
| P/OCF Ratio | 34.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.09, with an EV/FCF ratio of 61.12.
| EV / Earnings | 14.81 |
| EV / Sales | 19.72 |
| EV / EBITDA | 31.09 |
| EV / EBIT | 31.24 |
| EV / FCF | 61.12 |
Financial Position
The company has a current ratio of 0.35, with a Debt / Equity ratio of 0.57.
| Current Ratio | 0.35 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 13.69 |
| Debt / FCF | 26.91 |
| Interest Coverage | 2.29 |
Financial Efficiency
Return on equity (ROE) is 9.29% and return on invested capital (ROIC) is 1.87%.
| Return on Equity (ROE) | 9.29% |
| Return on Assets (ROA) | 1.66% |
| Return on Invested Capital (ROIC) | 1.87% |
| Return on Capital Employed (ROCE) | 2.64% |
| Weighted Average Cost of Capital (WACC) | 3.36% |
| Revenue Per Employee | 928,419 |
| Profits Per Employee | 1.24M |
| Employee Count | 93 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:YVIV has paid 47.60 million in taxes.
| Income Tax | 47.60M |
| Effective Tax Rate | 29.28% |
Stock Price Statistics
The stock price has decreased by -2.21% in the last 52 weeks. The beta is -0.01, so BME:YVIV's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -2.21% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 0.00 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YVIV had revenue of EUR 86.34 million and earned 114.95 million in profits. Earnings per share was 0.15.
| Revenue | 86.34M |
| Gross Profit | 78.76M |
| Operating Income | 54.50M |
| Pretax Income | 162.55M |
| Net Income | 114.95M |
| EBITDA | 54.77M |
| EBIT | 54.50M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 20.71 million in cash and 749.79 million in debt, with a net cash position of -729.08 million or -1.00 per share.
| Cash & Cash Equivalents | 20.71M |
| Total Debt | 749.79M |
| Net Cash | -729.08M |
| Net Cash Per Share | -1.00 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 1.79 |
| Working Capital | -43.71M |
Cash Flow
In the last 12 months, operating cash flow was 27.89 million and capital expenditures -26,000, giving a free cash flow of 27.86 million.
| Operating Cash Flow | 27.89M |
| Capital Expenditures | -26,000 |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | n/a |
| Free Cash Flow | 27.86M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 91.22%, with operating and profit margins of 63.12% and 133.13%.
| Gross Margin | 91.22% |
| Operating Margin | 63.12% |
| Pretax Margin | 188.27% |
| Profit Margin | 133.13% |
| EBITDA Margin | 63.43% |
| EBIT Margin | 63.12% |
| FCF Margin | 32.27% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | 242.42% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.12% |
| FCF Payout Ratio | 59.38% |
| Buyback Yield | -0.76% |
| Shareholder Yield | -0.26% |
| Earnings Yield | 11.61% |
| FCF Yield | 2.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |